Legal & General Group’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Legal & General Group’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,930	Closed	-$120K	–	3393
2023 Q4	$120K	Buy	1,930 +930	+93%	+$23.1K	﹤0.01%	2752
2023 Q3	$22.1K	Buy	+1,000	New	+$21K	﹤0.01%	2987

Legal & General Group's RYZB Position: Q1 2024 in Review

Legal & General Group sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 1,930 shares — an estimated $120K sold.

Legal & General Group first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $120K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Legal & General Group reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Legal & General Group sold 1,930 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $120K.
Legal & General Group first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Legal & General Group's RayzeBio, Inc. Common Stock position peaked at $120K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Legal & General Group's 13F filing for Q1 2024, filed 14 May 2024.